Greenbaum L E, Cressman D E, Haber B A, Taub R
Department of Genetics, Children's Hospital of Philadelphia, Pennsylvania 19104-6145, USA.
J Clin Invest. 1995 Sep;96(3):1351-65. doi: 10.1172/JCI118170.
During the period of rapid cell growth which follows a two-thirds partial hepatectomy, the liver is able to compensate for the acute loss of two-thirds of its mass to maintain serum glucose levels and many of its differentiation-specific functions. However certain hepatic transcription factors, C/EBP alpha and beta, which are important for establishment and maintenance of the differentiated state, have been shown to be antagonistic to cellular proliferation. To study the interplay between differentiation and cell growth in the liver regeneration model of hepatocyte proliferation, we characterized the expression of C/EBP alpha and beta transcription factors throughout the temporal course of liver regeneration. As determined by immunoblot, the level of C/EBP alpha decreases more than twofold during the mid to late G1 and S phase (8-24 h after hepatectomy) coordinately with a threefold increase in expression of C/EBP beta. Renormalization of the levels of these proteins occurs after the major proliferative phase. This inverse regulation of C/EBP alpha and beta results in up to a sevenfold increase in the beta / alpha DNA binding ratio between 3 and 24 h after hepatectomy that may have an important impact on target gene regulation. However, total C/EBP binding activity in nuclear extracts remains relatively constant during the 7-d period after hepatectomy. By immunohistochemistry, both C/EBP alpha and beta are expressed in virtually all hepatocyte nuclei throughout the liver during the temporal course of liver regeneration, and there is no exclusion of expression from hepatocytes that are expressing immediate-early gene products or undergoing DNA synthesis. The persistent expression of C/EBP alpha and beta isoforms predicts that C/EBP proteins contribute to the function of hepatocytes during physiologic growth and that significant amounts of these proteins do not inhibit progression of hepatocytes into S phase of the cell cycle.
在三分之二部分肝切除术后的细胞快速生长阶段,肝脏能够代偿其三分之二质量的急性损失,以维持血清葡萄糖水平及其许多分化特异性功能。然而,某些对分化状态的建立和维持很重要的肝转录因子C/EBPα和β,已被证明对细胞增殖具有拮抗作用。为了研究肝细胞增殖的肝再生模型中分化与细胞生长之间的相互作用,我们在肝再生的整个时间进程中对C/EBPα和β转录因子的表达进行了表征。通过免疫印迹测定,在G1期中期至后期和S期(肝切除术后8-24小时),C/EBPα的水平下降超过两倍,同时C/EBPβ的表达增加了三倍。这些蛋白质水平在主要增殖期后恢复正常。C/EBPα和β的这种反向调节导致肝切除术后3至24小时β/αDNA结合率增加高达七倍,这可能对靶基因调节产生重要影响。然而,肝切除术后7天内核提取物中的总C/EBP结合活性保持相对恒定。通过免疫组织化学,在肝再生的时间进程中,C/EBPα和β几乎在整个肝脏的所有肝细胞核中均有表达,并且表达立即早期基因产物或正在进行DNA合成的肝细胞中不存在表达排除现象。C/EBPα和β异构体的持续表达预示着C/EBP蛋白在生理生长过程中对肝细胞的功能有贡献,并且这些蛋白质的大量存在不会抑制肝细胞进入细胞周期的S期。